United Theranostics
PrivateLast Round
Early Funding
Jan 26, 2026
Total Funding Raised
$15M
Company Overview
United Theranostics is a healthcare company that provides molecular imaging and precision radiopharmaceutical therapy services for the treatment of complex cancers.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Medical Imaging, Biotechnology, Clinical Trials
Business Model
B2C
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
United Theranostics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
United Theranostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jan 26, 2026 | ||||
| Debt | Feb 11, 2025 |
United Theranostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Courage Capital Management | Early Funding |
United Theranostics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about United Theranostics's valuation, stock price, and market status.